Eclipse Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-07-2024
- Paid Up Capital ₹ 0.10 M
as on 10-07-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 52.34%
(FY 2022)
- Profit 85.02%
(FY 2022)
- Ebitda 367.02%
(FY 2022)
- Net Worth 14.23%
(FY 2022)
- Total Assets -16.55%
(FY 2022)
About Eclipse Biotech
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sumant Hippargekar and Sandhyarani Bongale serve as directors at the Company.
- CIN/LLPIN
U74900PN2012PTC144195
- Company No.
144195
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eclipse Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumant Hippargekar  | Director | 01-Oct-2017 | Current |
| Sandhyarani Bongale | Director | 26-Jul-2012 | Current |
Financial Performance of Eclipse Biotech.
Eclipse Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 52.34% increase. The company also saw a substantial improvement in profitability, with a 85.02% increase in profit. The company's net worth Soared by an impressive increase of 14.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eclipse Biotech?
Unlock access to Eclipse Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eclipse Biotech?
Unlock and access historical data on people associated with Eclipse Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eclipse Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eclipse Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
